Therapeutic insights into mechanisms that control vascular injury: Epigallocatechin 3-Gallate (EGCG), the major componet of green tea, ameliorates reendothelialization and suppresses neointima formation, 17/July/2014, 6.54 am

Therapeutic insights into the regulation of brown/white adipocyte determination: Tumor suppressor Menin (MEN1) promotes lipodystrophy via down regulation of its target gene, 17/July/2014, 6.21 am
July 17, 2014
Insights into the regulation of neocortex size: N-Myc regulates asymmetric neural stem cell division by increasing its target gene, 17/July/2014, 8.05 am
July 17, 2014
Show all

A study from the Department of Cardiology and Angiology, Hannover Medical School, Hannover, Germany;  Dept. of Cardiology, University Hospital Giessen & Marburg, Giessen, Germany; Institute for Cardiovascular Regeneration, Centre of Molecular Medicine, Goethe University, Frankfurt, Germany; Department of Cardiology and Angiology, Hannover Medical School, Hannover, Germany; Hubrecht Institute, Utrecht, The Netherlands.

This study has reported that “Inhibition of miR-92a improves re-endothelialization and prevents neointima formation following vascular injury.

This study was published in the June 27, 2014 Circulation Research [I.F >10] by Prof. Daniel G. Sedding,  Jan-Marcus Daniel and others from the Department of Cardiology and Angiology, Hannover Medical School, Hannover, Germany

On the foundation of this interesting finding, Dr L Boominathan, Director-cum-chief Scientist of GBMDreports here that: Therapeutic insights into mechanisms that control vascular injury: Epigallocatechin 3-Gallate (EGCG), the major component of green tea, ameliorates reendothelialization and suppresses neointima formation. Epigallocatechin 3-Gallate, by suppressing the expression of its target gene, it may prevent neointima formation. Together, this study suggests that pharmacological formulations encompassing “Epigallocatechin 3-Gallate”  can be used to ameliorate reendothelialization and suppress neointima formation following vascular injury. 

Idea Proposed/Formulated by: Dr L Boominathan PhD

Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/

Courtesy: When you cite drop us a line at info@genomediscovery.org

CitationBoominathan, Therapeutic insights into mechanisms that control vascular injury: Epigallocatechin 3-Gallate (EGCG), the major component of green tea, ameliorates reendothelialization and suppresses neointima formation, 17/July/2014, 6.54 am,  Genome-2-Bio-Medicine Discovery center (GBMD), http://genomediscovery.org

Web: http://genomediscovery.org

*Research cooperation

Comments are closed.